XML 112 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
At December 31, 2019 and 2018, our authorized capital was composed of 1.5 billion shares of common stock and 50 million shares of series preferred stock. Of the 281 million shares of common stock issued and outstanding as of December 31, 2019, 280 million shares were considered outstanding for consolidated balance sheet presentation purposes; the remaining shares were held in a separate trust. Of the 283 million shares of common stock issued and outstanding as of December 31, 2018, 281 million shares were considered outstanding for consolidated balance sheet presentation purposes; the remaining shares were held in a separate trust. No shares of preferred stock were issued and outstanding at December 31, 2019 or 2018.
Repurchases of Common Stock
During 2019, we repurchased 3.5 million shares of our common stock for $1.2 billion. During 2018 and 2017, we paid $1.5 billion and $2.0 billion to repurchase 4.7 million and 7.1 million shares of our common stock.
During the fourth quarter of 2019, we entered into an accelerated share repurchase (ASR) agreement to repurchase $350 million of our common stock. We paid $350 million and received an initial delivery of 658,886 shares on October 30, 2019. Upon final settlement of the ASR agreement on December 20, 2019, we received an additional delivery of 257,363 shares of our common stock based on the average price paid per share of $381.99, calculated with reference to the volume weighted average price per share of our common stock over the term of the agreement, less a negotiated discount. The transaction was accounted for as an equity transaction and recognized as a reduction of common stock and additional paid-in-capital, with the excess purchase price over par value recorded as a reduction of additional paid-in capital.

On September 26, 2019, our Board of Directors approved a $1.0 billion increase to our share repurchase program. Inclusive of this increase, the total remaining authorization for future common share repurchases under our program was $2.8 billion as of December 31, 2019. As we repurchase our common shares, we reduce common stock for the $1 of par value of the shares repurchased, with the excess purchase price over par value recorded as a reduction of additional paid-in capital. If additional paid-in capital is reduced to zero, we record the remainder of the excess purchase price over par value as a reduction of retained earnings. Due to the volume of repurchases made under our share repurchase program, additional paid-in capital was reduced to zero, with the remainder of the excess purchase price over par value of $713.0 million, $1.1 billion and $1.6 billion recorded as a reduction of retained earnings in 2019, 2018 and 2017.

Dividends

We paid dividends totaling $2.6 billion ($9.00 per share) in 2019, $2.3 billion ($8.20 per share) in 2018 and $2.2 billion ($7.46 per share) in 2017. We paid quarterly dividends of $2.20 per share during each of the first three quarters of 2019 and $2.40 per share during the fourth quarter of 2019; $2.00 per share during each of the first three quarters of 2018 and $2.20 per share during the fourth quarter of 2018; and $1.82 per share during each of the first three quarters of 2017 and $2.00 per share during the fourth quarter of 2017.
Accumulated Other Comprehensive Loss
Changes in the balance of AOCL, net of income taxes, consisted of the following (in millions):
 
 
Postretirement  
Benefit Plans (a)  
 
Other, net

 
AOCL

Balance at December 31, 2016
 
$
(11,981
)
 
$
(121
)
 
$
(12,102
)
Other comprehensive (loss) income before reclassifications
 
(1,380
)
 
120

 
(1,260
)
Amounts reclassified from AOCL
 
 
 
 
 

Recognition of net actuarial losses
 
1,030

 

 
1,030

Amortization of net prior service credits
 
(228
)
 

 
(228
)
Other
 

 
21

 
21

Total reclassified from AOCL
 
802

 
21

 
823

Total other comprehensive (loss) income
 
(578
)
 
141

 
(437
)
Balance at December 31, 2017
 
(12,559
)
 
20

 
(12,539
)
Other comprehensive loss before reclassifications
 
(501
)
 
(105
)
 
(606
)
Amounts reclassified from AOCL
 
 
 
 
 

Recognition of net actuarial losses
 
1,455

 

 
1,455

Amortization of net prior service credits
 
(253
)
 

 
(253
)
Other
 

 
30

 
30

Total reclassified from AOCL
 
1,202

 
30

 
1,232

Total other comprehensive (loss) income
 
701

 
(75
)
 
626

Reclassification of income tax effects from tax reform(b)
 
(2,396
)

(12
)

(2,408
)
Balance at December 31, 2018
 
(14,254
)
 
(67
)
 
(14,321
)
Other comprehensive loss before reclassifications
 
(2,182
)
 
18

 
(2,164
)
Amounts reclassified from AOCL
 
 
 
 
 

Recognition of net actuarial losses
 
1,148

 

 
1,148

Amortization of net prior service credits
 
(240
)
 

 
(240
)
Other
 

 
23

 
23

Total reclassified from AOCL
 
908

 
23

 
931

Total other comprehensive income (loss)
 
(1,274
)
 
41

 
(1,233
)
Balance at December 31, 2019
 
$
(15,528
)
 
$
(26
)
 
$
(15,554
)
(a) 
AOCL related to postretirement benefit plans is shown net of tax benefits of $4.2 billion at December 31, 2019, $3.9 billion at December 31, 2018 and $6.5 billion at December 31, 2017. These tax benefits include amounts recognized on our income tax returns as current deductions and deferred income taxes, which will be recognized on our tax returns in future years. See “Note 9 – Income Taxes” and “Note 11 – Postretirement Benefit Plans” for more information on our income taxes and postretirement benefit plans.
(b) 
During 2018, we reclassified the impact of the income tax effects related to the Tax Cuts and Jobs Act of 2017 (the Tax Act) from AOCL to retained earnings by the same amount with zero impact to total equity.